Will Palantir Crash?
AI and data analytics software major Palantir (NASDAQ:PLTR) has been…
Sell
35
RNAC Quote, Financials, Valuation and Earnings
Last price:
$10.33
Seasonality move
:
3.36%
Day range:
$10.04 - $10.43
52-week range:
$8.46 - $29.65
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
6.86x
P/B ratio:
568.21x
Volume:
31.1K
Avg. volume:
72K
1-year change:
-62.18%
Market cap:
$267.8M
Revenue:
$38.9M
EPS (TTM):
-$1.15
Earnings Data
Next earnings date for RNAC
Aug 08
2025
Most recent earnings per share
-$0.68
Missed by $0.68
(May 8/2025)
Consensus Estimate
--
(May 8/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
RNAC Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 08/08/2025 | Q2 | $771.4K | -- | -- | -- | -- |
| 05/08/2025 | Q1 | $687.5K | $1.1M | -$0.68 | -- | -- |
| 03/13/2025 | Q4 | $100K | -$759K | $0.12 | -- | -- |
| 11/07/2024 | Q3 | $1.8M | $387K | -$1.13 | -$0.55 | -$0.58 |
| 08/08/2024 | Q2 | $5.5M | $33.4M | $0.54 | -$0.10 | $0.64 |
| 05/08/2024 | Q1 | -- | $5.8M | -$10.50 | -$1.42 | -$9.08 |
| 03/07/2024 | Q4 | $2.5M | $8.3M | -$41.56 | -$1.50 | -$40.06 |
| 11/13/2023 | Q3 | -- | $6.6M | -$1.74 | -- | -- |
| 08/17/2023 | Q2 | -- | $5.2M | -$2.23 | -- | -- |
| 03/31/2023 | Q1 | -- | $5.9M | -$4.24 | -- | -- |
| 12/31/2022 | Q4 | -- | $16.8M | -$1.50 | -- | -- |
| 09/30/2022 | Q3 | -- | $20.7M | -$1.50 | -- | -- |
| 06/30/2022 | Q2 | -- | $39.3M | $1.80 | -- | -- |
| 03/31/2022 | Q1 | -- | $34M | $2.40 | -- | -- |
| 12/31/2021 | Q4 | -- | $29.9M | $0.90 | -- | -- |
| 09/30/2021 | Q3 | -- | $24.4M | -$4.80 | -- | -- |
| 06/30/2021 | Q2 | -- | $19.7M | -$0.06 | -- | -- |
| 03/31/2021 | Q1 | -- | $11.1M | -$6.60 | -- | -- |
| 12/31/2020 | Q4 | -- | $12M | -$4.20 | -- | -- |
| 09/30/2020 | Q3 | -- | $4.6M | -$2.70 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$7.50 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$6.30 | -- | -- |
| 12/31/2019 | Q4 | -- | $6.7M | -$8.40 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$7.80 | -- | -- |
| 06/30/2019 | Q2 | -- | $13K | -$11.10 | -- | -- |
| 03/31/2019 | Q1 | -- | $10K | -$9.30 | -- | -- |
| 12/31/2018 | Q4 | -- | $903K | -$19.50 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -$21.30 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$25.20 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$21.30 | -- | -- |
| 12/31/2017 | Q4 | -- | $17K | -$26.40 | -- | -- |
| 09/30/2017 | Q3 | -- | $27K | -$19.80 | -- | -- |
| 06/30/2017 | Q2 | -- | $26K | -$25.50 | -- | -- |
| 03/31/2017 | Q1 | -- | $137K | -$24.60 | -- | -- |
| 12/31/2016 | Q4 | -- | $2.9M | -$23.10 | -- | -- |
| 09/30/2016 | Q3 | -- | $1M | -$12.90 | -- | -- |
| 06/30/2016 | Q2 | -- | $2M | -$82.50 | -- | -- |
| 03/31/2016 | Q1 | -- | $2.1M | -$17.44 | -- | -- |
| 12/31/2015 | Q4 | -- | $2.1M | -$21.51 | -- | -- |
| 09/30/2015 | Q3 | -- | $1.6M | -$17.63 | -- | -- |
| 06/30/2015 | Q2 | -- | $1.2M | -$19.65 | -- | -- |
Cartesian Therapeutics Earnings Questions
-
How Much did Cartesian Therapeutics Generate in Revenue Last Quarter?
Cartesian Therapeutics reported $1.1M worth of top line sales in its most recent quarter.
-
Did Cartesian Therapeutics Beat Earnings Last Quarter?
Cartesian Therapeutics announced earnings per share of -$0.68 which represents a miss of analyst forecast a -- per share.
-
Is Cartesian Therapeutics Profitable?
Cartesian Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Cartesian Therapeutics EPS Next Year?
Cartesian Therapeutics's earnings are forecast to decrease from -$4.49 per share to -$4.12 per share next year representing a decrease of -91.96%.
-
When is Cartesian Therapeutics's Earnings Date?
Cartesian Therapeutics's next earnings date is August 8, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Target’s Dividend Worth Buying?
Retail giant Target (NYSE:TGT) has been through an extremely volatile…
Where Will AST SpaceMobile Be In 5 Years?
Ever tried to send a text from the Nevada desert…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 41x
Buy
60
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 49x
Sell
37
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
49
RGC alert for Jun 17
Regencell Bioscience Holdings [RGC] is up 24.07% over the past day.
Buy
75
ARQQ alert for Jun 17
Arqit Quantum [ARQQ] is down 0.62% over the past day.
Buy
59
SYM alert for Jun 17
Symbotic [SYM] is down 1.54% over the past day.
